HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,299,409 | +11.0% | 1,126,078 | +8.4% | 0.00% | – |
| Q2 2023 | $2,972,341 | +45.6% | 1,039,280 | +57.3% | 0.00% | – |
| Q1 2023 | $2,041,857 | -1.5% | 660,795 | -32.7% | 0.00% | – |
| Q4 2022 | $2,071,956 | +51.8% | 981,970 | +134.6% | 0.00% | – |
| Q3 2022 | $1,365,000 | +1.7% | 418,613 | +0.1% | 0.00% | – |
| Q2 2022 | $1,342,000 | -21.2% | 418,042 | +73.3% | 0.00% | – |
| Q1 2022 | $1,703,000 | +237.2% | 241,203 | +246.2% | 0.00% | – |
| Q4 2021 | $505,000 | – | 69,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |